This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Dow Inc. (DOW) Q1 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Dow Inc. (DOW) delivered earnings and revenue surprises of 56.76% and 4.52%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Univar (UNVR) Soars 12.0%: Is Further Upside Left in the Stock?
by Zacks Equity Research
Univar (UNVR) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
5 Stocks to Watch on Dividend Hikes Amid Spiking Inflation Rates
by Zacks Equity Research
Investors may keep a tab on BBVA, WAB, MBCN, ADI and AVNT, which have lately hiked their dividend payments to reward investors.
Avient (AVNT) Q4 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Avient (AVNT) delivered earnings and revenue surprises of 30% and 0.92%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Earnings Preview: Stepan Co. (SCL) Q4 Earnings Expected to Decline
by Zacks Equity Research
Stepan Co. (SCL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Analysts Estimate Avient (AVNT) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Avient (AVNT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
LyondellBasell (LYB) Q4 Earnings Beat Estimates
by Zacks Equity Research
LyondellBasell (LYB) delivered earnings and revenue surprises of 18.35% and 2.19%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Are Options Traders Betting on a Big Move in Avient (AVNT) Stock?
by Zacks Equity Research
Investors need to pay close attention to Avient (AVNT) stock based on the movements in the options market lately.
Avient (AVNT) Q3 Earnings and Revenues Lag Estimates
by Zacks Equity Research
Avient (AVNT) delivered earnings and revenue surprises of -3.28% and 3.23%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Kronos Worldwide (KRO) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Kronos Worldwide (KRO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Analysts Estimate Avient (AVNT) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Avient (AVNT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Chemours (CC) Surpasses Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Chemours (CC) delivered earnings and revenue surprises of 6.90% and 0.31%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Do Options Traders Know Something About Avient (AVNT) Stock We Don't?
by Zacks Equity Research
Investors need to pay close attention to Avient (AVNT) stock based on the movements in the options market lately.
Avient (AVNT) Beats Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Avient (AVNT) delivered earnings and revenue surprises of 5.38% and 1.11%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Methanex (MEOH) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Methanex (MEOH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Avient (AVNT) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Avient (AVNT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Northern Technologies (NTIC) Q3 Earnings and Revenues Miss Estimates
by Zacks Equity Research
Northern Technologies (NTIC) delivered earnings and revenue surprises of -20% and 0.18%, respectively, for the quarter ended May 2022. Do the numbers hold clues to what lies ahead for the stock?
Avient (AVNT) Moves 6.1% Higher: Will This Strength Last?
by Zacks Equity Research
Avient (AVNT) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Avient (AVNT) is a Top Dividend Stock Right Now: Should You Buy?
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Avient (AVNT) have what it takes? Let's find out.
Is Avient (AVNT) a Suitable Stock for Value Investors Now?
by Zacks Equity Research
Let's see if Avient (AVNT) stock is a good choice for value-oriented investors right now from multiple angles.
Are You Looking for a High-Growth Dividend Stock? Avient (AVNT) Could Be a Great Choice
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Avient (AVNT) have what it takes? Let's find out.
Avient (AVNT) Q1 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Avient (AVNT) delivered earnings and revenue surprises of 4.21% and 2.50%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Avient's (AVNT) Q4 Earnings and Sales Surpass Estimates
by Zacks Equity Research
Avient (AVNT) benefits from higher demand for sustainable solutions, healthcare applications and composites technologies amid headwinds from raw material and supply-chain disruptions in Q4.
Avient (AVNT) Q4 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Avient (AVNT) delivered earnings and revenue surprises of 5.45% and 4.64%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Chemical Stock Q4 Earnings Slated on Feb 8: DD, FMC & AVNT
by Anindya Barman
Chemical companies' Q4 results are likely to have been driven by higher demand and the benefits of strategic actions amid supply-chain headwinds. Let's see how DD, FMC and AVNT are poised ahead of their earnings releases.